Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

Editors’ Note: Dr. Mauskop reviews the literature on the use of butterbur extract for migraine prophylaxis and concludes that it has the potential for serious toxicity. Authors Holland et al. disagree with Dr. Mauskop's interpretation. Dr. Sethi, in response to Drs. Stone and Edwards' "Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs," airs the difficulty, which most neurologists can relate to, of discussing a psychogenic diagnosis with a patient. Dr. Tfelt-Hansen calls attention to an error in the classification of evidence in the American Academy of Neurology guideline on episodic migraine prevention by Silberstein et al. The authors concur and an erratum appears in this issue. Megan Alcauskas, MD, and Robert C. Griggs, MD

Source: Neurology - February 25, 2013 Category: Neurology Authors: Mauskop, A., Holland, S., Silberstein, S. D., Freitag, F., Dodick, D. W., Argoff, C. Tags: WRITECLICK: EDITOR ' S CHOICE Source Type: research